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Abstract
Somatic nuclear transfer is a cloning technique that shows great promise in the application to regenerative medicine.
Although cloned animals are genetically identical to their donor counterparts, abnormalities in phenotype and gene
expression are frequently observed. One hypothesis is that the cause of these abnormalities is due to epigenetic aberration.
In this report, we focused our analysis on the acetylation of histone H3 at lysine9 (H3K9Ac). Through the use of whole
genome tiling arrays and quantitative PCR, we examined this epigenetic event and directly compared and assessed the
differences between a cloned mouse (C1) and its parental nuclear donor (D1) counterpart. We identified 4720 regions of
chromosomal DNA that showed notable differences in H3K9Ac and report here many genes identified in these hyper- and
hypo-acetylated regions. Analysis of a second clone (C2) and its parental donor counterpart (D2) for H3K9Ac showed a high
degree of similarity to the C1/D1 pair. This conservation of aberrant acetylation is suggestive of a reproducible epigenetic
phenomenon that may lead to the frequent abnormalities observed in cloned mice, such as obesity. Furthermore, we
demonstrated Crp which was identified as a hyper-acetylated gene in this study is related to the body mass, suggesting that
Crp is a possible candidate of a cause for the abnormal obesity in cloned mice. In this, one of the first reports describing
genome-wide epigenetic abberation between parental and nuclear transfer-cloned mammals, we propose that aberrant
acetylation of histones (H3K9Ac) flanking promoter regions highly correlates with gene-expression and may itself be an
epigenetic change that accounts for variable expression patterns observed in cloned animals.
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Introduction
Because success in cloning techniques using somatic nuclear
transfer (NT) has led to the generation of genetically identical
animals, the technique is now being developed for regenerative
medicine. But despite substantial improvements in mouse NT
cloning during recent years [1–7], the cloning efficiency remains
low. The best success rate is only approximately7 percent [4].
After birth, cloned offspring frequently exhibit a variety of
abnormal phenotypes, some of which commonly include an
increased body weight (large fetus syndrome) [8], placental
overgrowth [9], immuno-system anomalies, and a short life span
[10]. Since the environment for fetal development largely
influences health and disease of post-natal life (so called ‘‘barker’s
hypothesis’’) [11,12], the abnormal phenotypes may be derived
from aberrations in nascent stage. Therefore, these low efficiency
and abnormalities may be a consequence of physical damages
from a piezo-assisted NT[13], epigenetic changes caused by in vitro
culture prior to implantation, and failure or incomplete nuclear-
reprogramming. Furthermore, different uterine environment from
the donor may contribute to the abnormalities as well. In many
labs, general attempts to identify abnormalities at a molecular level
revealed atypical profiles of gene expression compared to naturally
conceived animals. These abnormal gene expression patterns were
observed not only in early development, such as in embryos but
also in placentas and normally birthed cloned mice [14–17].
Kohoda et al. have reported that cloned mice offspring show an
over-diversity of gene expression compared to normal mice, but
common abnormalities are surprisingly few. They also showed
that some of these genes map in a linked cluster and are commonly
changed in the same manner. Taken together, this evidence
suggest that although there are many abnormalities caused by
random components, cloned mice indeed exhibit common
abnormalities that result from non-random components.
DNA methylation and histone modifications are known to be
important epigenetic events that control cellular morphology and
function [18,19]. There is now a growing body of evidence
suggesting that proper histone acetylation may be a critical
element in successful NT cloning. Treatment with trichostatin A
(TSA), a histone deacetylase inhibitor, after somatic nuclear
transfer significantly improves the mouse cloning not only in the
generation rate but also in reducing the abnormal phenotypes,
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e1905with the exception of placenta overgrowth [4], and enables mouse
cloning of an outbred strain[6]Furthermore, the developmental
potential of clones correlate with the histone acetylation levels in
rabbits [20] and primates[21]. These reports clearly indicate that
histone acetylation is a key element in animal cloning but the
mechanism that links histone acetylation to phenotypes remains
undetermined.
Acetylation of histone H3 at Lysine 9 (H3K9Ac), one of the
most well known epigenetic markers, is enriched in the promoter
region of activated genes [22–25]. The level of H3K9Ac in the
promoter strongly correlates to the gene expression. High density
oligo tiling arrays which cover entire genomes have enabled the
genome wide analysis not only of transcriptome by RNA mapping
[26–29] but also of protein-DNA interactions or histone
modifications by a combination with chromatin immunoprecip-
itation (ChIP) [22–24,30]. Hence, we have obtained genome-wide
data of H3K9Ac by using commercially available whole-genome
tiling arrays.
Application to a regenerative medicine, a comparison of clones
to their donor counterparts may provide more valuable insights
than comparing clones and normal animals. However, nearly all
studies of cloned mice so far, have focused on this latter
comparison. In the gene expression analysis, individual cloned
mice show diverse results, suggesting that combined data from
multiple cloned mice will not accurately represent abnormalities or
differences of significance [16]. Therefore, our approach focused
on investigating differences between a single cloned mouse and its
parental (donor) counterpart. In this report we characterized one
key epigenetic abnormality at the genome-wide level, analyzing
the level of H3K9Ac in the liver of the clone and that of its
parental (donor) counterpart by using whole-genome tiling arrays.
We identified genomic regions that showed a notable difference of
H3K9Ac between the mouse clone and donor and identified genes
in those regions whose promoters were either significantly hypo-
acetylated or hyper-acetylated. We also have shown that abnormal
gene expression in a cloned mouse often correlates with abnormal
H3K9Ac at their promoters. These findings suggest that, among
epigenetic factors, H3K9Ac may be one of the major causative
elements of abnormalities that need to be addressed for improving
success rates in animal cloning or perhaps applications in
regenerative medicine.
Results
H3K9 acetylation profiles of cloned mouse and its donor
mouse by ChIP on chip
To identify the H3K9Ac enriched sites, we performed ChIP
followed by tiling array analysis (ChIP on chip) using the Affymetrix
mouse tiling 1.0 array, which spans the entire mouse genome at a
30 bp resolution with 47 million 25-mer probes (excluding
repetitive sequence elements). Fixed chromatin preparations from
cloned mouse (C1) and donor mouse (D1) livers were immuno-
precipitated with an antibody directed against the H3K9Ac. The
immunoprecipitated DNA (treatment sample) and the control
DNA from a whole cell extract (WCE) were amplified by the
Ligation-Mediated PCR (LM-PCR) method and hybridized to the
tiling arrays as previously described [23]. As a measure of the
H3K9Ac enrichment, a P-value (P) was computed at each probe
position by assessing the excess of signal intensities detected by
probes located within6200 bp in the treatment relative to the
control sample by wilcoxon rank sum test [30]. Using P#10
24 as a
significant cut-off [22,23], we have identified 30902 and 32757
H3K9Ac enriched sites in the C1 and the D1 livers, respectively.
Among them, 9584 sites (31%) and 10201 sites (31%) were located
in the promoter regions which are defined as being61 kb from
transcription start site (TSS). The TSSs were determined by
aligning 470,133 RIKEN 59 ESTs[31] to the mouse genome, by
using BLAT[32] and SIM4[33]. These results clearly indicated
that the H3K9Ac enriched sites were biased toward the promoter
regions, which is consistent with previous studies performed on
human cell lines [22–25,34], and suggest this regional bias and
functions of H3K9Ac are conserved among higher eukaryotes.
Validation for tiling array data
Although ChIP on chip data is a useful mass screening tool, the
technology is less reliable for quantitation of DNA than many
other methods. Hence we selected quantitative PCR (qPCR) as a
validation tool and picked 43 genomic sites to test. No
consideration was given to the P-values of the selected sites but
rather they were chosen for their general dispersion across the
genome (Table S1). Of these 43 sites, 23 were in the gene
promoters and 20 sites were located among intergenic sequences.
Using identical immuno-precipitation techniques, we carried out
ChIP followed by qPCR (ChIP-qPCR) on the 43 sites [35]. qPCR
was achieved by real-time PCR and the enrichment of the ChIP
DNA as multiples of the WCE were computed for each site. The
quantitative values for enrichment as determined by ChIP-qPCR
were plotted against P-values measured by ChIP on chip (Figure 1A,
B). Sites displaying little to no enrichment [log2] measured by
ChIP-qPCR coordinately showed very low significance P-values as
measured by ChIP on chip (values of 10 and below in -10logP). In
the sites showing 2-fold enrichment and above ($log21), increasing
enrichment clearly correlates with an increasing significance level
of P-value. Out of 18 sites, Seventeen (17) sites which were
detected as P#10
24 yielded an enrichment greater than 4-fold in
ChIP-qPCR (11/11 in C1 liver, 6/7 in D1 liver). Based on this, we
conclude that the cut-off of P#10
24 is reliable to identify the
H3K9Ac enriched sites with little false positives and high certainty.
Furthermore, the total Pearson correlation coefficients were 0.68
and 0.74 in C1 and D1 liver samples, respectively. In addition,
from the data, we can interpret that amplification of ChIP DNA
by LM-PCR prior to hybridization to the tiling array did not
introduce a significant bias into the ChIP on chip results.
Promoter H3K9 acetylation differences between Cloned
and Donor mouse
Promoter regions are a major target for epigenetic studies to
explain gene expression level changes between cloned mice and
their parental counterparts. A comparison of the H3K9Ac ChIP on
chip tiling array P-values from over 16,000 promoter region data
points between C1 and D1 livers samples showed a high degree of
similarity, with a Spearman correlation coefficient of 0.898
(Figure 1C). However, to specifically identify and focus on
promoter regions where significant differences exist in H3K9Ac
levels between mouse clones and donors, signal intensities from
ChIP on chip tiling array data in the C1 sample relative to the D1
sample and vice versa were evaluated by the Wilcoxon rank sum test
[30]. In the cloned mouse (C1), 2550 hyper-acetylated sites and
2170 hypo-acetylated sites were identified with a P#10
24.O f
these sites, 113 and 147 sites respectively, were located in gene
promoter regions. These results establish that abnormal H3K9Ac
differences between a clone and a parental donor is not
significantly biased toward promoter regions, but rather scattered
across the chromosomal DNA.
In that changes in gene expression are ultimately responsible for
abnormalities in clones, we next focused our analysis on the
regions identified that mapped to promoters and were either
hyper- or hypo-acetylated at H3K9. To confirm abnormal
H3K9Ac Analysis in Cloned Mice
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primers designed by Primer3 software from sequence information
of the regions that were statistically significant at a P#10
24 or less.
From 113 hyper-acetylated and 147 hypo-acetylated site possibil-
ities, only 74 and 61 primer sets could be designed for validation
due to sequence constraints (Table S2). As before, ChIP DNA was
amplified by LM-PCR method followed by real-time PCR
measurement. The relative difference in the level of H3K9Ac
between the samples was computed as the change in the C1
relative to the D1 sample as log2 (C1/D1). Cut-off values for this
comparison were relaxed relative to the previous ChIP-qPCR
analysis because the reference material was another ChIP sample
(not WCE) and as a consequence, the results displayed more
variability. In addition, since the difference of H3K9Ac was
relatively insignificant between C1 and D1 (Figure 1C), cut-off
value should be looser to identify imperceptible differences.
Furthermore, stringency did not need to be high at this stage of
selection since a first screening was already performed by tiling
array data. Thus, we needed here sensitivity rather than specificity.
A significant increase (.0.5 [log2 (C1/D1)]) of an H3K9Ac level
in the C1 sample was detected on 26 hyper-acetylated sites
(Table 1), and a significant decrease (,20.5 [log2 (C1/D1)]) was
detected on 22 hypo-acetylated sites (Table 2).
Relationship between abnormalities of H3K9 acetylation
and gene expression
Previous studies have shown that the level of H3K9Ac in
promoter regions is strongly correlated with gene expression[23].
Our hypothesis was that hyper- and hypo-acetylation in the
promoter region leads to abnormal gene expression in a cloned
mouse. To test this hypothesis, the expression levels of the genes
whose promoters were hyper- or hypo-acetylated in the C1 and
D1 mice were measured by using qRT-PCR. Total RNA was
isolated from livers of the C1 and the D1 mice, and reverse-
transcribed with random hexamers. Using the cDNA as a
template, a real-time PCR measurement was performed using
coding region primers (Table S3) for the 26 hyper-acetylated genes
(Table 1) and 22 hypo-acetylated genes (Table 2) from the C1 and
D1 mice. We then determined the differences in gene expression
between the C1 liver and the D1 liver using the 2
2DDCt
method[36] (Figure 2). We detected 2-fold or greater increase in
the level of expression for 6 (23.1%) out of the 26 hyper-acetylated
genes, and none showed a 2-fold or greater decrease in gene
expression. For the 22 hypo-acetylated genes examined, we found
5 (21.7%) that showed 2-fold or greater decrease in the level of
expression and none that showed 2-fold or greater increase in
Table 1. Hyper-acetylated Genes of Mouse Clone (C1)
Change in acetylation
Accession No. Gene name Percent (%) log2
NM_145367.3 thioredoxin domain containing 5 (Txndc5) 187.15 0.90
NM_021462.2 MAP kinase-interacting serine/threonine kinase 2 (Mknk2) 180.98 0.86
NM_007886.1 dystrobrevin, beta (Dtnb) 177.55 0.83
NM_007768.2 C-reactive protein, pentraxin-related (Crp) 146.00 0.55
NM_030021.1 RIKEN cDNA D730039F16 gene (D730039F16Rik) 164.60 0.72
NM_172476.2 transmembrane channel-like gene family 7 (Tmc7) 222.29 1.15
NM_053183.1 DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 (Ddx50) 203.71 1.03
NM_024440.1 Der1-like domain family, member 3 (Derl3) 681.68 2.77
NM_010301.2 guanine nucleotide binding protein, alpha 11 (Gna11) 221.87 1.15
NM_177152.4 leucine-rich repeats and immunoglobulin-like domains 3 (Lrig3) 304.04 1.60
NM_177614.2 amplified in osteosarcoma (Os9) 141.57 0.50
NM_011814.2 fragile6mental retardation, autosomal homolog 2 (Fxr2), 160.83 0.69
NM_153103.1 kinesin family member 1C (Kif1c) 174.76 0.81
NM_023113.3 aspartoacylase (aminoacylase) 2 (Aspa) 145.37 0.54
NM_153804.3 pleckstrin homology domain containing, family G (with RhoGef domain) member 3 (Plekhg3) 149.89 0.58
NM_144836.2 solute carrier family 17 (sodium phosphate), member 2 (Slc17a2) 200.88 1.01
NM_183146.2 RIKEN cDNA A530054K11 gene (A530054K11Rik) 153.97 0.62
NM_001033988.1 nuclear receptor coactivator 4 (Ncoa4), transcript variant 2 160.09 0.68
NM_007447.2 angiogenin, ribonuclease A family, member 1 (Ang1) 145.98 0.55
NM_020271.2 pyridoxal (pyridoxine, vitamin B6) phosphatase (Pdxp) 389.88 1.96
NM_144942.1 cysteine sulfinic acid decarboxylase (Csad) 339.34 1.76
NM_133666.1 NADH dehydrogenase (ubiquinone) flavoprotein 1(Ndufv1) 151.52 0.60
NM_011697.1 vascular endothelial growth factor B (Vegfb) 158.46 0.66
NM_144873.1 ubiquitin-like, containing PHD and RING finger domains2 (Uhrf2) 160.35 0.68
NM_138595.1 glycine decarboxylase (Gldc) 214.93 1.10
NM_175507.2 transmembrane protein 20 (Tmem20) 174.02 0.80
The change in acetylation is displayed as both percent change (%) and log (base2) values for the C1 animal relative to D1. Each value represents the average of two
replicates ChIP-qPCR assays.
doi:10.1371/journal.pone.0001905.t001
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acetylation of H3K9Ac may contribute to a part of the abnormal
gene expression in the NT cloned mice, but is likely not the only
factor involved.
Conservation of H3K9Ac variation in other mouse clones
It is important to determine if the same aberrant acetylation
events are reproducible and lead to the reproducible abnormal
phenotypes observed in cloned mice. To investigate this, we
Table 2. Hypo-acetylated Genes of Mouse Clone (C1)
Change in acetylation
Accession No. Gene name Percent (%) log2
NM_001035531.1 adrenergic receptor kinase, beta 2 (Adrbk2), transcript variant 2 51.44 20.96
NM_007925.2 elastin (Eln) 35.82 21.48
NM_177678.4 actin-binding LIM protein 2 (Ablim2) 54.50 20.88
NM_153501.1 pantothenate kinase 2 (Hallervorden-Spatz syndrome) (Pank2) 54.62 20.87
NM_178768.3 RIKEN cDNA C230095G01 gene (C230095G01Rik) 11.53 23.12
NM_172759.1 carboxylesterase 5 (Ces5) 67.77 20.56
NM_009736.1 Bcl2-associated athanogene 1 (Bag1) 66.58 20.59
NM_010451.1 homeo box A2 (Hoxa2) 50.63 20.98
NM_026637.2 RIKEN cDNA A030007L17 gene (A030007L17Rik) 58.92 20.76
NM_175268.4 RIKEN cDNA A930008G19 gene (A930008G19Rik) 33.46 21.58
NM_212473.1 RIKEN cDNA A930008G19 gene (A930008G19Rik) 46.71 21.10
NM_030254.2 tumor suppressor candidate 3 (Tusc3) 61.09 20.71
NM_030152.2 nucleolar protein 3 (apoptosis repressor with CARD domain) (Nol3) 38.53 21.38
NM_133792.2 lysophospholipase 3 (Lypla3) 64.77 20.63
NM_009698.1 adenine phosphoribosyl transferase (Aprt) 60.82 20.72
NM_178933.2 organic solute transporter beta (Ostb) 41.38 21.27
NM_175206.2 F-box and leucine-rich repeat protein 22 (Fbxl22) 59.27 20.75
NM_153145.2 ATP-binding cassette, sub-family A (ABC1), member 8a (Abca8a) 25.92 21.95
NM_025695.3 structural maintenance of chromosomes 6 (Smc6) 15.98 22.65
NM_198301.1 cDNA sequence BC052328 (BC052328), 44.39 21.17
NM_054052.2 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (B3gnt5) 68.42 20.55
NM_027222.1 RIKEN cDNA 2010001M09 gene (2010001M09Rik) 40.01 21.32
The change in acetylation is displayed as both percent change (%) and log (base2) values for the C1 animal relative to D1. Each value represents the average of two
replicates ChIP-qPCR assays.
doi:10.1371/journal.pone.0001905.t002
Figure 2. Expression Modulation of Genes with Promoters Hyper- and Hypo-acetylated at H3K9. Hyper-acetylated genes (A) and Hypo-
acetylated genes (B) were pre-selected by ChIP on chip data and validated by ChIP-qPCR for alterations in H3K9Ac, and then analyzed for changes in
gene expression by qRT-PCR (n=2). Bars are shown as the average of duplicate assay results for changes in expression levels in C1 relative to D1.
Standard deviations are shown using error bars. Upper red dotted lines represent 2-fold increase and lower red dotted lines represent 2-fold
decrease.
doi:10.1371/journal.pone.0001905.g002
H3K9Ac Analysis in Cloned Mice
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was derived using the same cumulus cell NT technique. We
repeated the ChIP-qPCR experiment using the same primer sets
for 26 hyper- and 22 hypo-acetylated genes (Table S2) on ChIP
from the livers of the C2 and D2 mice. The change in acetylation
for each gene for the C1/D1 pair and C2/D2 pair (Figure 3A) was
statistically analyzed for group significance (Figure 3B). Among the
hyper-acetylated sites, the overall tendency of changes in the C2/
D2 pair was clearly biased toward the positive compared to all
(hyper- and hypo-acetylated) sites, with a P,0.05 (Welch’s t-test),
indicating statistical significance toward hyper-acetylation
(Figure 3B). On the other hand, the overall distribution of the
hypo-acetylated sites was biased toward negative change with a
P,0.05 (Welch’s t-test), indicating statistical significance toward
hypo-acetylation (Figure 3B). These results suggest that the
abnormalities in H3K9Ac patterns among cloned mice derived
from cumulus cells by NT tends to be conserved among cloned
individuals, and the abnormalities may be related to common
abnormal phenotypes of cloned mice.
Discussion
The abnormalities of cloned mice have been recognized not
only by phenotype [8–10] but also partially characterized by gene
expression [14–17]. The root causes of these abnormalities are
thought to be attributed to multiple factors. For instance, a
growing body of evidence has emerged to support the general
supposition that chromosomal abnormalities are one of the
elements for failures in animal cloning [13,37].Among these
factors, epigenetic factors are important elements for the successful
animal cloning[3,4,6,20,21]. However, the epigenetic properties
responsible for the aberrant cloned mouse phenotypes are poorly
understood. We have chosen to analyze H3K9Ac because much
evidence exists relating this epigenetic feature to active gene
expression [22–25]. Previous studies have focused on normal mice
as the reference control [9,10,14–17,38], but not specifically the
parental NT-donor mouse. A comparison of the clone with its
donor, more accurately identifies the variation of H3K9Ac that
occurs in cloning and suggests that a large number of genomic sites
are involved. We also examined whether the same H3K9Ac
alterations existed in two pairs of cumulus cell-derived cloned
mouse and parental donor pairs. Evidence showed that the
promoter region hyper- and hypo-acetylated sites detected in one
cloned mouse tended to be similar and statistically significant in
the other examined cloned mouse, as well. However, it is not clear
if this conservation of the H3K9Ac alteration pattern among
separate clones is an inheritance from the donor cell, or if it results
from the aberrant nuclear-reprogramming which is based on
common factors. To answer this question, further study is
required.
In higher eukaryotes, transcriptional regulation is complex.
Many factors and elements influence and directly regulate
transcription, such as transcriptional regulatory factors, DNA
methylation, and Chromatin structure. Furthermore, these
elements work together and clearly influence one other, establish-
ing a concerted functional ‘‘network’’ [39]. Although we
previously reported that the degree of H3K9Ac and gene
expression showed positive correlation, we also found many
examples that are not consistent with this observation [23].
Another group also reported that the histone modifications which
are known to be associated with active gene promoter are enriched
at both active and inactive promoters [34]. Hence, the cause of
abnormal gene expression is not solely a direct consequence of
H3K9Ac, but perhaps an indirect consequence or a contributing
factor influenced by other elements as well. From our experiments
looking at genes with aberrant H3K9Ac, almost one-fourth of the
hyper-acetylated genes we examined for expression in clone mouse
(C1) livers were up-regulated by more than 2-fold, and almost one-
fifth of the hypo-acetylated genes were down regulated when
compared to the donor animal (D1) liver. It is possible that
H3K9Ac increases the possibility of active transcription, but itself
is not sufficient [24,34]. The correlation between gene expression
and H3K9Ac presented in this study is consistent with the
possibility. This may explain the phenotypic variability in TSA
treated cloned mice. We believe that aberrant H3K9Ac in cloned
mice is a critical factor influencing abnormal gene expression, but
by simply looking at one tissue (such as liver in this study), or
Figure 3. Conservation of H3K9Ac variation in other mouse
clones. Acetylation-state changes of each promoter site in the cloned
mice are indicated by color, and as a multiple of corresponding donor
mice (A). No-change is represented as white, increased acetylation is
depicted as intensifying red color, and decreased acetylation is depicted
as intensifying yellow color. The value of each change is the average of
technical replicates (n=2). Details of the target genes are reported in
Table 1 and Table 2. (B) For each gene, the actual experimental values
for the C2/D2 pair is graphically aligned in categories of hyper- or hypo-
acetylation containing 26 and 22 genes, respectively, which is a
reflection of gene-state determined in the C1/D1 mouse pair. Medians
for each data set are indicated by black center lines, upper quartiles are
indicated by upper edges of the box, and lower quartiles are indicated
by lower edges of the box. Maximum and minimum values are marked
as end of lines extending from the boxes. Values which are more than
1.5 times the inter-quartile range from the upper or lower quartile are
represented as white circles and are considered outliers and not used in
the calculations. The red dotted horizontal line indicates the position of
median of all genes (hyper- and hypo-acetylated genes, total 48 genes).
doi:10.1371/journal.pone.0001905.g003
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fully determined. One interesting finding is that H3K9Ac enriched
sites are clearly biased toward gene promoters. However,
approximately two-thirds of H3K9Ac was also scattered among
the chromosomes, which is consistent with previous studies in
human [22–24,34]. Many intergenic sites (.2000) showed a
significant difference in the H3K9Ac between cloned and donor
mice in this study. Hence it is possible that H3K9Ac influences not
only to proximal regulatory elements in and around promoters,
but also distant regulatory elements, such as enhancers, silencers,
insulators, and locus control regions. This can also have a
significant impact on the expression of genes located in the
vicinity, and is an important subject for future investigation.
As a possible phenotype-related H3K9Ac aberration, we noted
C-reactive protein (Crp) is a hyper-acetylated gene identified in
this study (Figure 4A). Crp is now recognized as a potential
predictor of metabolic syndrome [40]. Although there are several
disputations [41–43], Chen et al. reported that Crp induces leptin
resistance, inhibiting the binding of leptin to its receptor [44]. In
humans and rodents, leptin concentration in the blood shows
strong positive correlation with body mass [45,46], which may be
explained by the leptin resistance [47,48]. Interestingly, one of the
common abnormal phenotypes in cloned mice is obesity and the
concentration of leptin in the blood is usually more than 10 times
higher than that of normal mice [8]. Hence, we speculated that the
reason for the obesity in cloned mice is the leptin resistance
induced by an excess of the Crp protein. To investigate a
relationship between the body mass and the Crp in cloned mice,
we measured mice body weight and the Crp protein level in serum
by the Enzyme-Linked ImmunoSorbent Assay (ELISA) from eight
(8) cloned mice treated with TSA. TSA treatment in mouse
cloning partially abrogates the tendency toward obesity, generat-
ing cloned mice that have the same background but various body
weights (Figure 4B, D). The Crp protein level in serum showed a
strong correlation with the weight of these animals (Figure 4C).
For this experiment, the Pearson correlation coefficient was 0.72.
This result suggests that cloned mice obesity could be related to
Crp. However, expression of the Crp mRNA was not significantly
changed in the C1 liver compared to D1 liver (Figure 2A). H3K9
hyper-acetylation may be not sufficient to increase the active
transcription [24,34]. Hence the abnormal Crp expression may
occur at another age and/or in another tissue in the obese cloned
animal and is a topic that warrants further investigation. In a
recent paper, Senda et al. report that abnormalities of clones fade
with aging[49]. The obesity actually appears 8 weeks after
birth[8]. Considering their result and our data, it is plausible to
assume that some abnormalities can escape the fading.
To our knowledge, this is the first report describing genome-
wide epigenetic aberration between donor and cloned animals. We
propose that epigenetic abnormalities, such as those in H3K9Ac
lead to abnormal gene expression, and that abnormal gene
expression results in abnormal phenotypes. Hence, controlling the
epigenetic landscape of a cell or by selecting a proper donor cell
type possessing epigenetic information suitable to cloning we may
be able to improve cloning success rates and the health of cloned
animals.
Materials and Methods
Production of Cloned mice
BDF1 (C57BL/66DBA/2) oocytes and fresh isolated BD129F1
(BDF16129/Sv) cumulus cells were collected and used for the
production of cloned mice as previously described [50]. A group of
oocytes was transferred to a droplet of HEPES-CZB [51]contain-
ing 5 mg/ml cytochalasin B, then metaphase II chromosome-
spindle complexes were removed from the oocytes by an
enucleation pipette. The donor cumulus cells were drawn in and
out of the injection pipette until the cell membrane was broken
and nuclei were injected one by one into an enucleated oocyte.
After nuclear transfer, the reconstructed oocytes were activated by
10 mM SrCl2 in Ca
2+-free CZB medium in the presence of 5 g/
mL cytochalasin B, and cultured for 24 h in CZB medium. When
cloned embryos were developed to the 2-cell stage, it was
transferred to the oviduct of foster mothers (ICR strain) which
had been mated with vasectomized ICR males 1 day previously.
All recipient females were euthanized at 19.5 dpc (days post
coitum) and pups raised by lactating ICR foster mothers. All
animals (obtained from SLC, Shizuoka, Japan, or bred in Riken)
were maintained in accordance with the Animal Experiment
Handbook at Riken Center of Developmental Biology.
Figure 4. Crp levels in the blood of adult TSA-treated cloned
mice of various weights. (A) Result of ChIP on chip analysis at the
region of the Crp gene. Horizontal axis represents alignment of Chr1
and the vertical axes represent P-value of tiling array intensity data. The
scale of the genome viewer is given as coordinate of Chr.1 (bp). Upper
tier (magenta) represents direct comparison of C1 ChIP sample vs. D1
ChIP sample, middle tier (green) represents D1 ChIP sample vs. WCE,
and lower tier (yarrow) represents C1 ChIP sample vs. WCE. Each vertical
line standing on the each tire represents positions of array probes and
its 210logP value. Horizontal lines in each tier represent P=10
24 and
filled bars being bottom of each tier represent regions which are
P,10
24 or less, respectively. Blue line represents the exon structure of
the Crp gene. (B) Photograph of TSA-treated mice used for Crp plasma
protein level measurements by ELISA. Right mouse is the leanest mouse
(TSA-5) and left mouse is the most obese mouse (TSA-8). (C) Crp protein
concentration in TSA-treated mouse clone serum measured by ELISA.
The vertical axis represents the concentration of Crp protein in serum
and the horizontal axis represents body weight. The concentration is
shown as the average of four technical replicates (n=4). Pearson
correlation coefficient for the test is 0.72. (D) General information of
TSA-treated mice. The information shows ID for the mice and
corresponding sex, age (month), and body weight.
doi:10.1371/journal.pone.0001905.g004
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Livers extracted from cloned and donor mice at the age of
2.5 month-old were homogenized using the BioMasher
TM extrac-
tion device (Nippi Corp.). ChIP experiments using an anti-
acetylated K9 histone H3 antibody (catalog no. 07-352, Upstate
Bio Corp.) were performed as described [23] with some
modification. Briefly, the homogenized samples were fixed with
1% formaldehyde, resuspended in TE buffer (pH8.0), and
fragmented to a size range of 200 to 1000 bases using a SonifierH
S-450 (Branson Crop.) with a cup horn. The fragmented chromatin
was pre-cleared with protein G sepharose after adding 100 mM
NaCl and 0.4% NP-40. After removal of a control aliquot (whole
cell extract, WCE), pre-cleared lysates were incubated at 4uC
overnight adding the anti-acetylated K9 histone H3 antibody. The
immune complexes were precipitated with protein G DynabeadsH
(Invitrogen Dynal Corp.), washed and eluted from beads into
elution buffer (100 mM NaHCO3, 1% SDS). The WCE aliquot
andtheelutedimmunecomplexes were reversecross-linkedat 65uC
for 3.5h and treated with RNase and Proteinase K. The DNA from
WCE and the ChIP DNA was extracted using phenol/chloroform
method and ethanol precipitation.
Ligation Mediated-PCR (LM-PCR) and array hybridization
LM-PCR and array hybridization were performed as previously
described [23]. Briefly, the blunted ChIP DNAs and WCE DNAs
were ligated with the annealed oligonucleotides, amplified by using
Blend Taq
TM-Plus (Cosmo Bio Corp.). The amplified DNA was
purified, fragmented with DNase I, and end-labeled with biotin-
ddATP by using terminal deoxytransferase. The labeled fragments
were hybridized to the GeneChipH Mouse Tiling 1.0 Array Set
(Affymetrix Corp.). The arrays were washed, and scanned using
the Affymetrix GeneChipH System. Each sample was hybridized
and tested as duplicate samples.
Level of enrichment for acetylation of lysine 9 of histone
H3 in the whole mouse genome
The hybridization intensities (background-subtracted intensity,
PM–MM where PM and MM indicate intensities detected by a
25-mer perfectly matching and another one-base-mismatching to
genome, respectively.) of the probes were measured in two
technical replicates for each of the treatment and control samples,
and were mapped to the genome using exact 25-mer matching to
mouse genome (NCBI version 32). Raw array data were quantile
normalized within treatment/control replicate groups and scaled
to a median feature intensity of 500. A shift of the intensities in the
treatment relative to control data in a 400 bp window centered at
each probe was evaluated by a Wilcoxon Rank Sum test, which
assigned a P-value to the probe position [22,23]. We used the
Affymetrix software, TAS (http://www.affymetrix.com/support/
developer/downloads/TilingArrayTools) for the P-value calcula-
tion. All tiling array data including raw signal intensity and
calculated P-value are available in Center for Information Biology
gene EXpression database (CIBEX) (http://cibex.nig.ac.jp/)
accession number CBX38.
Profile of acetylation at lysine 9 of histone H3 in
promoter region of protein-coding genes in donor and
cloned mice
The profile of H3K9Ac enrichment in the promoter region
(61 kb of TSS) of protein-coding genes was compared between
the donor and cloned mice. Using the 59 ends of mRNA sequences
(18,707 transcripts in 16,720 loci downloaded on Jan. 19, 2006
from RefSeq database: ftp://ftp.ncbi.nih.gov/refseq) aligned to
genome as TSS, we attempted to measure the magnitude of
H3K9Ac enrichment in the promoter region. The alignment was
carried out by using BLAT[32] and SIM4[33]. For the
comparison of the H3K9Ac enrichment between the donor and
cloned mice, we averaged 210 log P detected by the probes
located in the promoter region, and computed correlation
coefficient (Spearman).
Real-time PCR
PCR primers for evaluating ChIP assays (Table S1) were
designed to amplify 70–150 base pair fragments from the genomic
regions indicated for validation of ChIP on chip data, and for
identification of the H3K9 hyper- or hypo-acetylated genes (Table
S2). PCR amplification was performed on an ABI PRISMH 7500
Sequence Detection System (Applied Biosystems, Inc.). For
amplification, SYBR Premix Ex Taq
TM (Takara Corp.) was used
as instructed in the manual. The PCR conditions were an initial
step of 10 sec at 95uC, followed by 40 cycles of 3 sec at 95uC and
20 sec at 62.5uC. To generate a standard curve for each amplicon,
Ct values of serially diluted WCE DNA which extracted in ChIP
experiment (5 ng, 2.5 ng, 1.25 ng, 0.625 ng, and 0.3125 ng) were
determined and plotted against the amount of WCE DNA
template. ChIPed DNA was measured by real-time PCR in
duplicates and the median of the average Ct values of all the
amplicons in each sample was scaled to 22. The amount of an
amplicon was estimated from the standard curve. Enrichment,
(fold change or relative enrichment) was determined as multiple of
the amount for each amplicon.
Quantitative Reverse Transcription-Polymerase Chain
Reaction (qRT-PCR)
Total RNA was extracted from the livers of the D1 and C1 mice
by the acid phenol–guanidinium thiocyanate–chloroform method
[52]. Reverse transcription of total RNA was achieved with
PrimeScript
TM Reverse Transcriptase (Takara Corp.) and random
hexamers in accordance with the manufacturer’s protocol.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA
which yielded a amplicon of 76 bp was used as a control (primers
59-TGTGTCCGTCGTGGATCTGA-39 and 59-CCTGCTT-
CACCACCTTCTTGA-39) for data normalization. The PCR
primers used for each gene in this analysis are given (Table S3).
PCR amplification using the real-time PCR was performed as
described above. Changes of gene expression were determined
using the 2
2DDCt method [36].
Enzyme-Linked ImmunoSorbent Assay (ELISA)
Blood was taken from the eyeground vein of eight TSA-treated
cloned mice. After blood clotting, the serum from each sample was
recovered as a supernatant by centrifugation. The C-Reactive
Protein (CRP) ELISA (High-Sensitivity), Mouse kit (cat. #KT-
095, Kamiya Biomedical Company) was used to measure the Crp
levels in the serums in accordance with the manufacturer’s
protocol.
Supporting Information
Table S1 ChIP-qPCR Primers used for validation of the tiling
array data.
Found at: doi:10.1371/journal.pone.0001905.g001 (0.02 MB
XLS)
Table S2 Hyper- or hypo-acetylated sites (start and end position
on the mouse genome NCBI version 32) and primers used for
ChIP-qPCR.
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XLS)
Table S3 Hyper- or hypo-acetylated genes and corresponding
coding region primers used for qRT-PCR.
Found at: doi:10.1371/journal.pone.0001905.g001 (0.02 MB
XLS)
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